Sprout Pharms Drug Patent Portfolio

Sprout Pharms owns 1 orange book drug protected by 4 US patents Given below is the list of Sprout Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7151103 Method of treating female hypoactive sexual desire disorder with flibanserin 09 May, 2028
Active
US8227471 Treating sexual desire disorders with flibanserin 09 May, 2023 Expired
US9468639 Treating sexual desire disorders with flibanserin 16 Oct, 2022 Expired
US7420057 Stable polymorph of flibanserin 01 Aug, 2022 Expired


Given below is the list of recent legal activities going on the following drug patents of Sprout Pharms.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 10 Jan, 2024 US8227471
Patent Term Extension Certificate 19 Nov, 2021 US7151103
FITF set to NO - revise initial setting 05 Mar, 2021 US7151103
Notice of Final Determination -Election Required 05 Mar, 2021 US7420057
Notice of Final Determination -Election Required 05 Mar, 2021 US7151103
Payment of Maintenance Fee, 4th Year, Large Entity 07 Apr, 2020 US9468639
Payment of Maintenance Fee, 12th Year, Large Entity 24 Feb, 2020 US7420057
Payment of Maintenance Fee, 8th Year, Large Entity 14 Jan, 2020 US8227471
Email Notification 08 Oct, 2019 US7151103
Change in Power of Attorney (May Include Associate POA) 08 Oct, 2019 US7151103
Correspondence Address Change 07 Oct, 2019 US7151103
Change in Power of Attorney (May Include Associate POA) 03 Oct, 2019 US7420057
Correspondence Address Change 02 Oct, 2019 US7420057
FDA Final Eligibility Letter 03 Jul, 2019 US7420057
FDA Final Eligibility Letter 03 Jul, 2019 US7151103


Sprout Pharms's Family Patents

Sprout Pharms drugs have patent protection in a total of 31 countries. It's US patent count contributes only to 23.2% of its total global patent coverage. 23 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Sprout Pharms Drug List

Given below is the complete list of Sprout Pharms's drugs and the patents protecting them.


1. Addyi

Addyi is protected by 4 patents, out of which 3 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7151103 Method of treating female hypoactive sexual desire disorder with flibanserin 09 May, 2028
(3 years from now)
Active
US8227471 Treating sexual desire disorders with flibanserin 09 May, 2023
(1 year, 5 months ago)
Expired
US9468639 Treating sexual desire disorders with flibanserin 16 Oct, 2022
(1 year, 11 months ago)
Expired
US7420057 Stable polymorph of flibanserin 01 Aug, 2022
(2 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Addyi's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List